Overview

Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

Status:
Completed

Trial end date:
2019-12-15

Target enrollment:

Participant gender:

Summary

This randomized phase III trial studies armodafinil to see how well it works in reducing cancer-related fatigue in patients with high grade glioma. Armodafinil may help relieve fatigue in patients with high grade glioma.

Phase:

Phase 3

Details

Lead Sponsor:

Alliance for Clinical Trials in Oncology

Collaborator:

National Cancer Institute (NCI)

Treatments:

Armodafinil
Modafinil